Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kenya pharmacy PrEP study shows new ways to boost HIV prevention access

NCT ID NCT05842122

First seen Jan 07, 2026 · Last updated May 25, 2026 · Updated 17 times

Summary

This study tested different ways to offer HIV prevention pills (PrEP) at pharmacies in Kenya. Over 5,800 people took part across 60 pharmacies. The goal was to see if getting PrEP directly at the pharmacy, instead of being sent to a clinic, helps more people start and keep taking the medication. Results will show which approach works best for expanding access.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Kenya Medical Research Institute

    Kisumu, Kenya

  • Partners in Health & Research Development

    Thika, Kenya

Conditions

Explore the condition pages connected to this study.